B- and T-lymphocyte attenuator (BTLA), partial (Active), human, recombinant

B- and T-lymphocyte attenuator (BTLA), partial (Active), human, recombinant
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
CSB-MP773799HU.20 20 µg -

10 - 14 Werktage*

216,00 €
CSB-MP773799HU.100 100 µg -

10 - 14 Werktage*

388,00 €
CSB-MP773799HU.1 1 mg -

10 - 14 Werktage*

3.202,00 €
 
Organism: Homo sapiens (Human). Source: Mammalian cell. Expression Region: 31-150aa. Protein... mehr
Produktinformationen "B- and T-lymphocyte attenuator (BTLA), partial (Active), human, recombinant"
Organism: Homo sapiens (Human). Source: Mammalian cell. Expression Region: 31-150aa. Protein Length: Partial. Tag Info: C-terminal hFc-Myc-tagged. Target Protein Sequence: KESCDVQLYI KRQSEHSILA GDPFELECPV KYCANRPHVT WCKLNGTTCV KLEDRQTSWK EEKNISFFIL HFEPVLPNDN GSYRCSANFQ SNLIESHSTT LYVTDVKSAS ERPSKDEMAS. Purity: Greater than 90% as determined by SDS-PAGE. Endotoxin: Less than 1.0 EU/ug as determined by LAL method. Biological Activity: ?Measured by its binding ability in a functional ELISA. Immobilized BTLA at 5 µg/ml can bind biotinylated human TNFRSF14 (CSB-MP842173HU-A), the EC50 is 137.8-233.4 ng/ml. Form: Lyophilized powder. Buffer: Lyophilized from a 0.2 µm filtered PBS, 6% Trehalose, pH 7.4. Reconstitution: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20 °C/-80 °C. Our default final concentration of glycerol is 50%. Customers could use it as reference. Storage: The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself. Generally, the shelf life of liquid form is 6 months at -20 °C/-80 °C. The shelf life of lyophilized form is 12 months at -20 °C/-80 °C. Notes: Repeated freezing and thawing is not recommended. Store working aliquots at 4 °C for up to one week. Relevance: Inhibitory receptor on lymphocytes that negatively regulates antigen receptor signaling via PTPN6/SHP-1 and PTPN11/SHP-2 (PubMed:12796776, PubMed:14652006, PubMed:15568026, PubMed:18193050). May interact in cis (on the same cell) or in trans (on other cells) with TNFRSF14 (PubMed:19915044). In cis interactions, appears to play an immune regulatory role inhibiting in trans interactions in naive T cells to maintain a resting state. In trans interactions, can predominate during adaptive immune response to provide survival signals to effector T cells (PubMed:19915044). Reference: n/a. Function: nan
Schlagworte: CD272, B- and T-lymphocyte attenuator, B- and T-lymphocyte-associated protein, Recombinant Human B- and T-lymphocyte attenuator (BTLA), partial (Active)
Hersteller: Cusabio
Hersteller-Nr: MP773799HU

Eigenschaften

Anwendung: Active protein
Konjugat: No
Wirt: Mammalian cells
Spezies-Reaktivität: human
MW: 43.9 kD
Reinheit: >90% (SDS-PAGE)
Format: Lyophilized

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier folgen Informationen zur Produktreferenz. mehr
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "B- and T-lymphocyte attenuator (BTLA), partial (Active), human, recombinant"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen